GPCR — Structure Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00Annual balance sheet for Structure Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 107 | 90.8 | 467 | 884 | 1,446 |
| Net Total Receivables | — | — | — | — | 100 |
| Prepaid Expenses | |||||
| Total Current Assets | 109 | 93.1 | 474 | 891 | 1,570 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1.79 | 1.29 | 8.36 | 7.01 | 12.9 |
| Other Long Term Assets | |||||
| Total Assets | 111 | 97.8 | 482 | 903 | 1,584 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 8.66 | 13 | 24.7 | 36 | 63.3 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 8.93 | 13 | 29.1 | 38.5 | 67.5 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 102 | 84.8 | 453 | 865 | 1,516 |
| Total Liabilities & Shareholders' Equity | 111 | 97.8 | 482 | 903 | 1,584 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |